Significant shareholders:

Shareholder/Beneficial OwnerShares% ISC
Invesco142,478,48317.78
T Rowe Price Global Investments96,897,77912.09
Canaccord Genuity Wealth Management58,176,9387.26
Hargreaves Lansdown, stockbrokers54,721,2296.83
Dr Andrew W Nelson*36,140,4174.54
Interactive Investor33,019,5104.12
AXA Framlington Investment Managers26,335,6063.29
Barclays Smart Investor24,679,4033.08

as at 30 April 2021

Quoted: AIM (London Stock Exchange)

Other Exchanges / Trading Platforms: The Company is not listed on any other exchanges or trading platforms.

Number of securities in issue: 800,788,829 Ordinary shares

Shares not in public hands: Insofar as the Company is aware, the percentage of securities that is not in public hands is 33.8%, these being held by directors, their families and significant shareholders.

Own shares held in treasury: There are currently no IQE plc shares held in treasury.

Details on any restrictions on the transfer of securities: There are no restrictions on the transfer of securities.

Applicable code(s): The Company is subject to the UK City Code on Takeovers and Mergers. The Code is administered by The Panel and Takeovers in Mergers.

* Per the Company’s RNS announcement of 11 May 2020, 12,121,711 Ordinary Shares of Dr Nelson’s total beneficial interest are subject to a Sale and Repurchase Agreement with Equities First Holdings